Senior Financial Analyst Corporate Finance (M&A and BD)
Exelixis
September 30, 2026
Full-time
Remote friendly (Alameda, CA)
Worldwide
Corporate Functions
Role: Senior Financial Analyst supporting biotech and pharma corporate development, M&A, and strategic planning. Responsibilities include conducting valuation analyses for licensing and acquisitions, building merger models, evaluating in-licensing opportunities, and preparing deal summaries for leadership. It also involves developing long-term financial models, performing discounted cash flow and company valuations, and analyzing lifecycle management initiatives to inform investment decisions. The role requires creating standardized financial analysis tools, assessing funding options, and benchmarking against industry peers. Collaboration with cross-functional teams and presenting insights to executive management are key activities. Qualifications: BS/BA with 5+ years or MBA with 3+ years of experience in finance, investment banking, management consulting, or biotech/pharma industry; strong proficiency in financial modeling, Excel, PowerPoint, and analytics tools like FactSet, Bloomberg, or Capital IQ. Skills include strategic analysis, problem-solving, communication, industry knowledge, and the ability to manage multiple projects. No travel required. High-value specifics: biotech/pharma sector, corporate finance, valuation, licensing/M&A activities, lifecycle management, and industry benchmarking.